GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,000 | 0.0% | 16,140 | +45.7% | 0.00% | – |
| Q2 2023 | $61,000 | +52.5% | 11,076 | +22.0% | 0.00% | – |
| Q1 2023 | $40,000 | -20.0% | 9,079 | -29.5% | 0.00% | – |
| Q4 2022 | $50,000 | +35.1% | 12,875 | +85.6% | 0.00% | – |
| Q3 2022 | $37,000 | -14.0% | 6,936 | +4.9% | 0.00% | – |
| Q2 2022 | $43,000 | -35.8% | 6,613 | -26.9% | 0.00% | – |
| Q1 2022 | $67,000 | -40.7% | 9,043 | -44.0% | 0.00% | – |
| Q4 2021 | $113,000 | -21.0% | 16,162 | +183.6% | 0.00% | – |
| Q3 2021 | $143,000 | +21.2% | 5,698 | +30.2% | 0.00% | – |
| Q2 2021 | $118,000 | -33.7% | 4,376 | -29.9% | 0.00% | – |
| Q1 2021 | $178,000 | +196.7% | 6,242 | +192.9% | 0.00% | – |
| Q4 2020 | $60,000 | +400.0% | 2,131 | +432.8% | 0.00% | – |
| Q3 2020 | $12,000 | +50.0% | 400 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |